Report cover image

Global Human Embryonic Stem Cells (HESC) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 191 Pages
SKU # APRC20278736

Description

Summary

According to APO Research, The global Human Embryonic Stem Cells (HESC) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, Viacyte, Inc., UK Stem Cell Bank, TATAA Biocenter, Takara Bio, STEMCELL Technologies, Reliance Life Sciences and R&D Systems (Biotrchne), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Embryonic Stem Cells (HESC), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Human Embryonic Stem Cells (HESC), also provides the sales of main regions and countries. Of the upcoming market potential for Human Embryonic Stem Cells (HESC), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Embryonic Stem Cells (HESC) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Human Embryonic Stem Cells (HESC) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Human Embryonic Stem Cells (HESC) sales, projected growth trends, production technology, application and end-user industry.

Human Embryonic Stem Cells (HESC) Segment by Company

ESI BIO
Thermo Fisher
Viacyte, Inc.
UK Stem Cell Bank
TATAA Biocenter
Takara Bio
STEMCELL Technologies
Reliance Life Sciences
R&D Systems (Biotrchne)
PerkinElmer
MilliporeSigma (Merck)
Fujifilm Cellular Dynamics
BioTime
BD Biosciences
Asterias Biotherapeutics
Astellas Institute of Regenerative Medicine
Human Embryonic Stem Cells (HESC) Segment by Type

Unipotent Stem Cells
Pluripotent Stem Cells
Totipotent Stem Cells
Human Embryonic Stem Cells (HESC) Segment by Application

Research
Clinical Trials
Others
Human Embryonic Stem Cells (HESC) Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Embryonic Stem Cells (HESC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Embryonic Stem Cells (HESC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Embryonic Stem Cells (HESC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Embryonic Stem Cells (HESC) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Embryonic Stem Cells (HESC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Embryonic Stem Cells (HESC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Embryonic Stem Cells (HESC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Human Embryonic Stem Cells (HESC) Market Size, 2020 VS 2024 VS 2031
1.3 Global Human Embryonic Stem Cells (HESC) Market Size Estimates and Forecasts (2020-2031)
1.4 Global Human Embryonic Stem Cells (HESC) Sales Estimates and Forecasts (2020-2031)
1.5 Global Human Embryonic Stem Cells (HESC) Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Human Embryonic Stem Cells (HESC) Market Dynamics
2.1 Human Embryonic Stem Cells (HESC) Industry Trends
2.2 Human Embryonic Stem Cells (HESC) Industry Drivers
2.3 Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges
2.4 Human Embryonic Stem Cells (HESC) Industry Restraints
3 Human Embryonic Stem Cells (HESC) Market by Manufacturers
3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturers (2020-2025)
3.2 Global Human Embryonic Stem Cells (HESC) Sales by Manufacturers (2020-2025)
3.3 Global Human Embryonic Stem Cells (HESC) Average Sales Price by Manufacturers (2020-2025)
3.4 Global Human Embryonic Stem Cells (HESC) Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Human Embryonic Stem Cells (HESC) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Embryonic Stem Cells (HESC) Manufacturers, Product Type & Application
3.7 Global Human Embryonic Stem Cells (HESC) Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Human Embryonic Stem Cells (HESC) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Embryonic Stem Cells (HESC) Players Market Share by Revenue in 2024
3.8.3 2024 Human Embryonic Stem Cells (HESC) Tier 1, Tier 2, and Tier 3
4 Human Embryonic Stem Cells (HESC) Market by Type
4.1 Human Embryonic Stem Cells (HESC) Type Introduction
4.1.1 Unipotent Stem Cells
4.1.2 Pluripotent Stem Cells
4.1.3 Totipotent Stem Cells
4.2 Global Human Embryonic Stem Cells (HESC) Sales by Type
4.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Type (2020-2031)
4.2.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2020-2031)
4.3 Global Human Embryonic Stem Cells (HESC) Revenue by Type
4.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2020-2031)
4.3.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2020-2031)
5 Human Embryonic Stem Cells (HESC) Market by Application
5.1 Human Embryonic Stem Cells (HESC) Application Introduction
5.1.1 Research
5.1.2 Clinical Trials
5.1.3 Others
5.2 Global Human Embryonic Stem Cells (HESC) Sales by Application
5.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Application (2020-2031)
5.2.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2020-2031)
5.3 Global Human Embryonic Stem Cells (HESC) Revenue by Application
5.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2020-2031)
5.3.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2020-2031)
6 Global Human Embryonic Stem Cells (HESC) Sales by Region
6.1 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Human Embryonic Stem Cells (HESC) Sales by Region (2020-2031)
6.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Region (2020-2025)
6.2.2 Global Human Embryonic Stem Cells (HESC) Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Human Embryonic Stem Cells (HESC) Revenue by Region
7.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region
7.1.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region (2020-2025)
7.1.3 Global Human Embryonic Stem Cells (HESC) Revenue by Region (2026-2031)
7.1.4 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Human Embryonic Stem Cells (HESC) Revenue (2020-2031)
7.2.2 North America Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Human Embryonic Stem Cells (HESC) Revenue (2020-2031)
7.3.2 Europe Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue (2020-2031)
7.4.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 ESI BIO
8.1.1 ESI BIO Comapny Information
8.1.2 ESI BIO Business Overview
8.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio
8.1.5 ESI BIO Recent Developments
8.2 Thermo Fisher
8.2.1 Thermo Fisher Comapny Information
8.2.2 Thermo Fisher Business Overview
8.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio
8.2.5 Thermo Fisher Recent Developments
8.3 Viacyte, Inc.
8.3.1 Viacyte, Inc. Comapny Information
8.3.2 Viacyte, Inc. Business Overview
8.3.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio
8.3.5 Viacyte, Inc. Recent Developments
8.4 UK Stem Cell Bank
8.4.1 UK Stem Cell Bank Comapny Information
8.4.2 UK Stem Cell Bank Business Overview
8.4.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio
8.4.5 UK Stem Cell Bank Recent Developments
8.5 TATAA Biocenter
8.5.1 TATAA Biocenter Comapny Information
8.5.2 TATAA Biocenter Business Overview
8.5.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio
8.5.5 TATAA Biocenter Recent Developments
8.6 Takara Bio
8.6.1 Takara Bio Comapny Information
8.6.2 Takara Bio Business Overview
8.6.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio
8.6.5 Takara Bio Recent Developments
8.7 STEMCELL Technologies
8.7.1 STEMCELL Technologies Comapny Information
8.7.2 STEMCELL Technologies Business Overview
8.7.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio
8.7.5 STEMCELL Technologies Recent Developments
8.8 Reliance Life Sciences
8.8.1 Reliance Life Sciences Comapny Information
8.8.2 Reliance Life Sciences Business Overview
8.8.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio
8.8.5 Reliance Life Sciences Recent Developments
8.9 R&D Systems (Biotrchne)
8.9.1 R&D Systems (Biotrchne) Comapny Information
8.9.2 R&D Systems (Biotrchne) Business Overview
8.9.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio
8.9.5 R&D Systems (Biotrchne) Recent Developments
8.10 PerkinElmer
8.10.1 PerkinElmer Comapny Information
8.10.2 PerkinElmer Business Overview
8.10.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio
8.10.5 PerkinElmer Recent Developments
8.11 MilliporeSigma (Merck)
8.11.1 MilliporeSigma (Merck) Comapny Information
8.11.2 MilliporeSigma (Merck) Business Overview
8.11.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio
8.11.5 MilliporeSigma (Merck) Recent Developments
8.12 Fujifilm Cellular Dynamics
8.12.1 Fujifilm Cellular Dynamics Comapny Information
8.12.2 Fujifilm Cellular Dynamics Business Overview
8.12.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio
8.12.5 Fujifilm Cellular Dynamics Recent Developments
8.13 BioTime
8.13.1 BioTime Comapny Information
8.13.2 BioTime Business Overview
8.13.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio
8.13.5 BioTime Recent Developments
8.14 BD Biosciences
8.14.1 BD Biosciences Comapny Information
8.14.2 BD Biosciences Business Overview
8.14.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio
8.14.5 BD Biosciences Recent Developments
8.15 Asterias Biotherapeutics
8.15.1 Asterias Biotherapeutics Comapny Information
8.15.2 Asterias Biotherapeutics Business Overview
8.15.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio
8.15.5 Asterias Biotherapeutics Recent Developments
8.16 Astellas Institute of Regenerative Medicine
8.16.1 Astellas Institute of Regenerative Medicine Comapny Information
8.16.2 Astellas Institute of Regenerative Medicine Business Overview
8.16.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio
8.16.5 Astellas Institute of Regenerative Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Human Embryonic Stem Cells (HESC) Value Chain Analysis
9.1.1 Human Embryonic Stem Cells (HESC) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Embryonic Stem Cells (HESC) Production Mode & Process
9.2 Human Embryonic Stem Cells (HESC) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Embryonic Stem Cells (HESC) Distributors
9.2.3 Human Embryonic Stem Cells (HESC) Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.